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Purpose: Endoscopic dextranomer/hyaluronic acid copolymer (Dx/HA) injection is a safe and efﬁcacious
treatment option for vesicoureteral reﬂux (VUR) in children. Endoscopic appearance, hydrodistention and
amount of injected Dx/HA have been demonstrated not to be reliable predictors of outcome. Aim of this study
was to evaluate Dx/HAmounds on ultrasound scans (US) and ﬁnd out any eventual correlationwith reﬂux resolution.
Methods:We selected patients treated with endoscopic injection for moderate to high VUR, renal scaring or repeated
infections under antibiotic prophylaxis. Success was deﬁned by absence of VUR at control 3 months after surgery; at
3 months we also measured mound height ultrasonographically.
Results: We considered a total of 32 children (15 male, 17 female; 53 ureters) with a median age of 3 years
(±24 months). Overall success rate was 77% per ureter. Success rate correlates directly with age and inversely with
VUR grade. Mound height is the major predictive parameter for reﬂux resolution (sensitivity 100%, speciﬁcity 65.9%);
mean mound heights of success-group vs. persistence-of-reﬂux group were 9.97 ± 1.61 mm and 7.29 ±
1.74 mm respectively (p b 0.0005).
Conclusion: A mound measuring at least 9.8 mm at post-operative US scan is a predictor of reﬂux resolution.
Age and grade also seems to inﬂuence success rate.
© 2016 Elsevier Inc. All rights reserved.Vesicoureteral reﬂux (VUR) is a common urological disease affecting
approximately 0.4–1.8% of pediatric populationwhohave not presented
with urinary tract infection (UTI) and up to 10–40% in patients who
presented a UTI [1]. Common consequences of VUR in children are
pyelonephritis and renal scarring [2].
Endoscopic injection of dextranomer/hyaluronic acid copolymer
(Dx/HA) is a safe and efﬁcacious treatment option for VUR in children,
especially because of its minimally invasiveness, high success rate and
low complication rate. Advantages of the technique are the reduced
hospital stay, reduced perioperative morbidity, quicker return to every-
day activity and better quality of life.
Many authors tried to correlate the appearance of the Dx/HAmound
with the outcome of the procedure [3]. Some studies demonstrated that
the endoscopic appearance of the Dx/HA mound [4] and lack oflymer; ROC, receiver operating
ns; ANOVA, univariate analysis
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http://dx.doi.org/10.1016/j.jphydrodistention [5] at the completion of the procedure are not reliable
predictors of outcome. All concluded that postoperative voiding
cystourethrogram (VCUG) is still required to truly determine reﬂux
resolution. However, VCUG remain an uncomfortable and stressful
procedure for both children and parents. Ultrasound scans (US) are
routinely performed during post-operative follow-up for VUR patients
and represent a less invasive and less expensive monitoring tool.
Aim of this study was to evaluate dextranomer–hyaluronic acid
copolymer mounds on ultrasound scans post-operatively and ﬁnd out
any eventual correlation with VCUG results, in order to deﬁne it as a
predictive sign that could reduce the need for VCUG during follow-up
for patients treated with endoscopic Dx/HA injection for VUR.
1. Material and methods
We considered all consecutive patients referred to our urologic out-
patient clinic between March 2013 and January 2015 for vesicoureteral
reﬂux. Sex, age, VURgrade and sidewere collected for each children.We
included in the study patients with reﬂux grade 3 to 5 conﬁrmed by
VCUG and patients with grade 2 VUR and persistent upper urinary
tract infections.
Exclusion criteria were grade 1 VUR, presence of voiding dysfunc-
tion, presence of other complex syndromes, presence of ectopic ureteralght as predictor of vesicoureteral reﬂux resolution after endoscopic
edsurg.2016.01.021
2 E. Zambaiti et al. / Journal of Pediatric Surgery xxx (2016) xxx–xxxoriﬁce at cystoscopy. Presence of voiding dysfunction or other
syndromes were assessed by an accurate clinical history at referral.
Of 52 patients referred, 32 (15 boys, 17 girls; 53 ureters)matched in-
clusion criteria and parents gave informed consent, after being informed
about the nature of the study, in accordance with the Helsinki declara-
tion. The study protocol was approved by the Ethics Committee of the
“P. Giaccone” University Hospital in Palermo, Italy.
All eligible patients underwent pre-operative protocol assessment as
described below and all VUR were treated with multiple intra-ureteric
submucosal injection of Dx/HA. Demographic of patients included in
the study is detailed in Table 1.1.1. Pre-operative evaluation
Standard pre-operative evaluation included history, physical exam-
ination, renal and bladder ultrasonography, urinalysis and VCUG.
US bladder and renal evaluation were performed by a single expert
sonographer using a 5 MHz convex probe (LOGIQ E9; GE Healthcare,
Milwaukee, WI, USA). Optimal images for a complete bladder evalua-
tion were obtained through sagittal and transverse scans; images for
renal evaluation were obtained through sagittal, transverse, oblique
scans, even through intercostal space or posteriorly if necessary. VCUG
was performed by an expert radiologist; VUR was graded according to
international guidelines. Same sonographer and VCUG-radiologist per-
formed both pre-operative evaluation and post-operative assessment
double blinded.
Indications for endoscopic treatment included repeated infections
on antibiotic prophylaxis, presence of scarring at renal scintigraphy
and/or moderate- to high-grade reﬂux.
All patients were taking prophylactic antibiotic before the procedure
and continued the prophylaxis until resolution of VUR was conﬁrmed
by VCUG control.1.2. Surgical procedure
All procedures were performed under general anesthesia with the
patient in supine position. A single experienced surgeon performed
all injections.
Using a 9 Fr cystoscope, the ureteral oriﬁce was hydrodistended to
evaluate the intramural course of the ureter and an endoscopic injection
with the double hit technique as described by Kirsch [6] was performed.
The bladder was kept half full, avoiding overdistension.
Dx/HA was injected trying to obtain a single mound; if mound was
not satisfactory, the needle was repositioned and the process repeated.
Improper initial placement and subsequent repeat injection occasionally
resulted in bilobed or trilobed mounds. The bladder was then emptied
and the procedure terminated.Table 1
Pre-operative demographic.
Pre-operative demographic
Patient, sex (M/F) 15 M 17 F
Age at surgery, mean ± SD (range) 35 ± 24 months (12 months–9 years)
Unilateral VUR, N°(%) 11 (32)
Bilateral VUR, N°(%) 21 (68)
Ureters 53
Side VUR, N°(%) 26 (49) R; 27 (51) L





Sex, age at surgery, side and grade of reﬂux, are recorded for each patient. VUR: vesico-
ureteral reﬂux; M: male; F: female; L: left side; R: right side.
Please cite this article as: Zambaiti E, et al, Ultrasonographic mound hei
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All patients underwent a post-operative follow-up consisting of
seriate urinary tract US and VCUG. Seriate US were performed at day 1
post-operatively and 3 months after surgery by the same sonographer
who evaluated the child pre-operatively, blinded to VCUG results.
Renal and bladder ultrasonography performed at day 1, before
discharge from the clinic, aimed to assess presence of any eventual
upper tract dilation; subsequent US at months 3 after surgery, aimed
to determine shape and localization of the Dx/HA mound. The mound
was visualized as a round-shaped mass with increased echogenicity lo-
calized at ureteral oriﬁce in transverse vesical sections at post-operative
US (Fig. 1). In case of bilobed or trilobed mounds, “mound height” was
considered as the maximal measurable height. A VCUG was performed
at 3 months after surgery to conﬁrm reﬂux resolution by a radiologist
blinded to US. Success was considered as a complete resolution of VUR
at 3-months VCUG control. All images were retrospectively reviewed
in consensus by the authors.
1.4. Statistical analysis
Statistical analysis of quantitative and qualitative data, including
descriptive statistics, was performed for all items. Continuous data are
expressed as mean ± SD, unless otherwise speciﬁed. Baseline differ-
ences between groups were assessed by the chi-square test or Fisher
exact test, as needed for categorical variables, and by the univariate
analysis of variance (ANOVA) for parametric variables. Spearman's rho
correlation coefﬁcient was calculated to measure the strength of the re-
lationship between US results with VCUG postop ﬁndings. Multinomial
logistic regression analysis examined the correlation between patient
characteristics (independent variables), and success of the procedure
(dependent variable) in simple and multiple regression models. To
assess the predictive rate of different cutoff values of post operative
mound height at US scan with regard to success rate, a receiver
operating characteristic (ROC) curve with calculations of area under
the curve and 95% CI was constructed, and sensitivity and speciﬁcity
values were calculated.
Data were analyzed by IBM SPSS Software 22 version (IBM Corp.,
Armonk, NY, USA). All p-values were two-sided and p b 0.05 was con-
sidered statistically signiﬁcant.
2. Results
We analyzed a total of 32 patients, counting for 53 ureters,
underwent Dx/HA injection for grade 2 to 5 VUR conﬁrmed by pre-
operative VCUG. Of the 32 patients, 15 were males. VUR was unilateral
in 11 (32%) and bilateral in 21 (68%) children. Of the 53 ureters, 26
were right-sided and 27 left-sided. Pre-operative VUR grade was 2, 3,
4 and 5 in 11.3% (n = 6), 28.3% (n = 15), 49.1% (n = 26), 11.3%
(n= 6) of the ureters respectively. All patients were treated with mul-
tiple subureteral injections of Dx/HA. Average age at surgery was 35
(SD ± 24) months, ranging from 12 months to 9 years. Most patients
had an intra-operative mound classiﬁed as “volcano” at endoscopic ap-
pearance, few bilobed and trilobedmoundswere recorded. The average
volume of Dx/HA injected was 0.85 (SD± 0.39)mL. Only 2 cases devel-
oped transitional slight upper tract dilation at early post-operative US
scan, that spontaneously resolved at following controls. Two patients
(1 female/1 male) developed controlateral reﬂux after the procedure,
but both were successfully treated with a subsequent Dx/HA injection.
The mean interval between surgery and post-operative US with
mound measurement was 3 months (SD ± 1.46).
The overall success rate, deﬁned as no VUR at VCUG, was 77.4% by
ureter. Success rate by gradewas 100%, 86.6%, 80.7%, and 50% for grades
2, 3, 4 and 5 respectively. The success by age was 62.5% for ﬁrst, 92% for
second and 100% older than third years respectively. However in thisght as predictor of vesicoureteral reﬂux resolution after endoscopic
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Fig. 1.Mound height, transverse vesical sections at post-operative ultrasound scan. The mound is visualized as a round-shaped mass localized at ureteral oriﬁce.
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signiﬁcant difference.
Of the 12 failure of the procedure, half showed a downgrading of the
reﬂux and half a persistent VUR (6/12). Of these 7 were treated by a
second injection, 4 were treated by open surgery and 1 spontaneously
resolved once completed potty-training.
A strong correlation was found between mound height on post-
operative US and VCUG (Spearman's rho correlation coefﬁcient =
−0.571; p b 0.0005). Moreover, success of endoscopic treatment
group had a mean mound height of 9.97 ± 1.61 mmwhile persistence
of reﬂux group had a mean mound height of 7.29 ± 1.74 mm
(p b 0.0005, ANOVA test). Other features of these two groups are
detailed in Table 2.
Logistic regression analysis in the simple model showed a relation-
ship between mound height and success of endoscopic treatment
(OR = 0.391 CI 95%; 0.23–0.67; p = 0.001). Multivariable regression
model conducted by evaluation of all different variables, evennot signif-
icant, maintained a signiﬁcant correlation between success of endo-
scopic treatment group with mound height (OR =0.178; 0.06–0.52;
p = 0.001) and evidenced a negative relationship even with VUR
grade (OR=4.1 CI95%: 1.2–16.0; p=0.046). The other analyzed factors
do not correlate with success/failure of the procedure: no differences
were found according to sex (p = 0.745, Fisher exact test), age (p =
0.282, ANOVA test), side of the VUR (p = 0.327, Fisher exact test) or
volume of Dx/HA injected (p = 0.348, ANOVA test).Table 2
Comparison between success and persistence of reﬂux groups.
Features Success (n = 41)
Sex (M/F) 21/20
Age at surgery (months), mean ± SD 37 ± 23
Side VUR (right/left), N° 22/19
Pre-operative VUR grade 2 N°(%) 5 (12.2)
Pre-operative VUR grade 3 N°(%) 12 (29.3)
Pre-operative VUR grade 4 N°(%) 21 (51.2)
Pre-operative VUR grade 5 N°(%) 3 (7.3)
Amount of Dx/HA (ml), mean ± SD 0.81 ± 0.37
Mound height (mm), mean ± SD 9.97 ± 1.61
VUR: vesico-ureteral reﬂux; M: male; F: female; L: left side; R: right side; Dx/HA: dextranome
⁎ Chi-square test or Fisher exact test;
# Univariate analysis of variance (ANOVA test).
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of 9.8 mm is a predictor of reﬂux resolution with a sensitivity of 100%
and a speciﬁcity of 65.9%, with an area under the ROC curve of 0.890
(95% CI 0.774 to 0.959; p = 0.0001).
3. Discussion
Subureteral injection of bulking agents for VUR treatment in
children is nowadays accepted as an efﬁcacious, safe and minimally in-
vasive procedure and it usually constitutes the ﬁrst line treatment op-
tion. Overall success rate, recently, has been proved to vary from 69%
to 86% irrespectively to grade [7,8]. However, despite this high success
rate, factors predisposing to success or failure of the procedure are not
fully understood andmany authors tried to identify whether any aspect
could suggest reﬂux resolution and thus allow tohypothesize prognosis.
Effect of voiding dysfunction on success rate of Dx/HA injection is
still unclear. Capozza et al. [9] noted that almost all patients with
treatment failure who had displacement of the Dx/HA mound also had
concomitant voiding dysfunction and ascribed displacement to high
voiding pressures secondary to voiding dysfunction.
Lavelle et al. [3] did not show a signiﬁcant difference in the cure rate
among patients with and without voiding dysfunction, concluding that
voiding dysfunction could not be a contraindication, relative or
otherwise, to Dx/HA injection. Because of its unclear role in VUR, we
considered voiding dysfunction unresponsive to treatment an exclusionPersistence of reﬂux (n = 12) p
5/7 0.745⁎






0.93 ± 0.44 0.348#
7.29 ± 1.74 p b 0.0005#
r/hyaluronic acid copolymer; US: ultrasound scan.
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Fig. 2. ROC curve for mound height. A value of 9.8 mm is a predictor of reﬂux resolution
with a sensitivity of 100% and a speciﬁcity of 65.9%, area under the ROC curve 0.890
(95% CI 0.774 to 0.959; p = 0.0001).
4 E. Zambaiti et al. / Journal of Pediatric Surgery xxx (2016) xxx–xxxcriteria. Moreover, in our case series, younger patients, ranging from 12
to 23 months and thus not fully toilet-trained, showed a higher persis-
tence of reﬂux to treatment if compared to older children, even if this
did not reach statistical signiﬁcance.
The ﬁnal endoscopic appearance as a predictor of success, regardless
of technique, also do not ensure a favorable result. Puri et al. [10] ﬁrst
described the “volcano” morphology, a cone-shaped mound with a
coated ureteral oriﬁce at its apex, but not evaluated statistically success
rate. Lavelle et al. [3] described this morphology as successful in 87% of
cases, compared with 53%when “other”morphology was present. They
described “other” morphology as bilobed or trilobed mounds resulting
from attempts to correct a poorly placed initial injection, producing a
mound in other than the desired location. However, Hidas et al. [5]
created an online survey based on 11 primary vesicoureteral reﬂux
cases e-mailed to 104 pediatric urologists and concluded that the
appearance of the Dx/HA mound and lack of hydrodistention at the
completion of the procedure are not reliable predictors of outcome. In
our opinion the sole volcano appearance cannot be an acceptable
predictor of successful outcome because it is not a reliable parameter
and it is strongly operator dependent and could vary signiﬁcantly with
endo-vesical pressures.
Amount of dextranomer/hyaluronic acid copolymer injected does
not correlate with success rate. Lavelle et al. [3] also reported a case
series of 52 patients with a volume injected of 0.94 mL in patients
with failure compared to 0.84mL in successful injections. This apparently
anomalous ﬁnding is justiﬁed by the authors as the result of subsequent
attempts to correct an endoscopic morphology other than volcano
obtained after ﬁrst injection.
In recent years some authors also tried to correlate the implant ap-
pearance at post-operative US scans with the success of the procedure.
Park et al. [11] described three implant appearance at US scans, correlat-
ing “large” implants with resolution of VUR at control VCUG, but they
did not precisely measure implant volumes. The same result was
obtained by McMann et al. [12] who also stated a good correlation
between volume retention of the implant and VCUG results. These
authors also demonstrated that after the initial volume reduction at
2 weeks from surgery, the Dx/HA mound remained durable withPlease cite this article as: Zambaiti E, et al, Ultrasonographic mound hei
treatment in children, J Pediatr Surg (2016), http://dx.doi.org/10.1016/j.jpinsigniﬁcant further volume reduction. In the present study we were
able to set a precise cut-off point for mound US appearance. The
achievement of a mound measuring at least 10 mm on post-operative
scan and localized in the correct position, could suggest a successful
procedure, because of the demonstrated strong correlation with VCUG
results. Therefore it is important to assess volume and location of
mound post-operatively using US, thus allowing to avoid post-
operative VCUG in the presence of a mound greater than 10 mm or
suggest further controls if this result is not achieved.
The present study has some limitations. First, the retrospective na-
ture of the study could have introduced some sampling bias. A prospec-
tive study comparing long-term clinical outcome could validate US
appearance of Dx/HA mound as prognostic factor for successful treat-
ment. Second, the limited number of patients with indication to endo-
scopic injection for VUR could be improved by a larger case series to
further conﬁrm our data. Above all, an increased numerosity could
lead to signiﬁcant inﬂuence of age and pre-operative VUR grade for re-
ﬂux resolution: our results only showed a slight direct correlation be-
tween success of the procedure and age and an inverse correlation
with pre-operative VUR grade. Third, ultrasonography is an operator-
dependent modality, particularly measuring small sizes.4. Conclusion
In conclusion, the present study demonstrates a strong correlation
between mound appearance at US and VCUG results: mounds
measuring at least 9.8 mm in height were associated with success of
the procedure, while smaller implants suggest the need for further
assessment. Post-operative US could be used as a ﬁrst line screening
examination in the follow-up of VUR patients treated with Dx/HA
injection, thus allowing to select those requiring VCUG to exclude
persistence of VUR.Acknowledgements
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